The molluscan neuropeptide FMRfamide: Calcium-dependent release and blood levels in Macrocallista (bivalvia)

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Ganglia dissected from the marine bivalve, Macrocallista nimbosa, were pooled and incubated in a series of seawater media designed to promote or inhibit the release of the neuropeptide PheMetArgPheNH2 (FMRFamide). The amount of peptide released, determined by radioimmunoassay (RIA), was enhanced two to seven times when the medium contained high potassium. FMRFamide release was reversibly inhibited when calcium was omitted from the high potassium medium. Immunoreactive FMRFamide was found in Macrocallista hemolymph in a concentration (10-9M) that excites isolated Macrocallista ventricles. Although the in vivo release sites have not yet been localized, these findings already show that the endogenous neuropeptide FMRFamide can be characterized as a neurohormone or as a neurotransmitter in Macrocallista.

Original languageEnglish (US)
Pages (from-to)803-807
Number of pages5
JournalLife sciences
Volume30
Issue number10
DOIs
StatePublished - Mar 8 1982
Externally publishedYes

Fingerprint

FMRFamide
Bivalvia
Neuropeptides
Blood
Calcium
Neurotransmitter Agents
Potassium
Hemolymph
Seawater
Ganglia
Radioimmunoassay
Peptides

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

The molluscan neuropeptide FMRfamide : Calcium-dependent release and blood levels in Macrocallista (bivalvia). / Nagle, Gregg Thomas.

In: Life sciences, Vol. 30, No. 10, 08.03.1982, p. 803-807.

Research output: Contribution to journalArticle

@article{f2ff833d2eba4e6fba033b9b1a4d707f,
title = "The molluscan neuropeptide FMRfamide: Calcium-dependent release and blood levels in Macrocallista (bivalvia)",
abstract = "Ganglia dissected from the marine bivalve, Macrocallista nimbosa, were pooled and incubated in a series of seawater media designed to promote or inhibit the release of the neuropeptide PheMetArgPheNH2 (FMRFamide). The amount of peptide released, determined by radioimmunoassay (RIA), was enhanced two to seven times when the medium contained high potassium. FMRFamide release was reversibly inhibited when calcium was omitted from the high potassium medium. Immunoreactive FMRFamide was found in Macrocallista hemolymph in a concentration (10-9M) that excites isolated Macrocallista ventricles. Although the in vivo release sites have not yet been localized, these findings already show that the endogenous neuropeptide FMRFamide can be characterized as a neurohormone or as a neurotransmitter in Macrocallista.",
author = "Nagle, {Gregg Thomas}",
year = "1982",
month = "3",
day = "8",
doi = "10.1016/0024-3205(82)90592-6",
language = "English (US)",
volume = "30",
pages = "803--807",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - The molluscan neuropeptide FMRfamide

T2 - Calcium-dependent release and blood levels in Macrocallista (bivalvia)

AU - Nagle, Gregg Thomas

PY - 1982/3/8

Y1 - 1982/3/8

N2 - Ganglia dissected from the marine bivalve, Macrocallista nimbosa, were pooled and incubated in a series of seawater media designed to promote or inhibit the release of the neuropeptide PheMetArgPheNH2 (FMRFamide). The amount of peptide released, determined by radioimmunoassay (RIA), was enhanced two to seven times when the medium contained high potassium. FMRFamide release was reversibly inhibited when calcium was omitted from the high potassium medium. Immunoreactive FMRFamide was found in Macrocallista hemolymph in a concentration (10-9M) that excites isolated Macrocallista ventricles. Although the in vivo release sites have not yet been localized, these findings already show that the endogenous neuropeptide FMRFamide can be characterized as a neurohormone or as a neurotransmitter in Macrocallista.

AB - Ganglia dissected from the marine bivalve, Macrocallista nimbosa, were pooled and incubated in a series of seawater media designed to promote or inhibit the release of the neuropeptide PheMetArgPheNH2 (FMRFamide). The amount of peptide released, determined by radioimmunoassay (RIA), was enhanced two to seven times when the medium contained high potassium. FMRFamide release was reversibly inhibited when calcium was omitted from the high potassium medium. Immunoreactive FMRFamide was found in Macrocallista hemolymph in a concentration (10-9M) that excites isolated Macrocallista ventricles. Although the in vivo release sites have not yet been localized, these findings already show that the endogenous neuropeptide FMRFamide can be characterized as a neurohormone or as a neurotransmitter in Macrocallista.

UR - http://www.scopus.com/inward/record.url?scp=0020053327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020053327&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(82)90592-6

DO - 10.1016/0024-3205(82)90592-6

M3 - Article

C2 - 7070195

AN - SCOPUS:0020053327

VL - 30

SP - 803

EP - 807

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 10

ER -